Brooklyn ImmunoTherapeutics Inc

ASE:BTX   2:18:49 PM EDT
12.52
+0.28 (+2.29%)
Earnings Announcements

Brooklyn ImmunoTherapeutics Announces Second Quarter 2021 Financial Results

Published: 08/16/2021 11:24 GMT
Brooklyn ImmunoTherapeutics Inc (BTX) - Brooklyn Immunotherapeutics Announces Second Quarter 2021 Financial Results.
Brooklyn Immunotherapeutics Inc - Qtrly Loss per Share $0.24.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be $0.00

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.